Medical Ikkou Group Co (TSE:3353) Piotroski F-Score: 5 (As of Jul. 15, 2026) — 17% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3353 Medical Ikkou Group Co Ltd TSE:3353
68 GF Score
Price 円2,841.00
GF Value 円3,534.01
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medical Ikkou Group Co Piotroski F-Score?

Medical Ikkou Group Co TSE:3353 +0.53% 68 Piotroski F-Score is 5 as of Jul. 15, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates TSE:3353 with a GF Score™ of 68/100 and a GF Value™ of 円3,534.01 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 559 Conglomerates companies, Medical Ikkou Group Co ranks better than 51.52% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medical Ikkou Group Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Medical Ikkou Group Co's Piotroski F-Score or its related term are showing as below:

TSE:3353' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 9
Current: 5

During the past 13 years, the highest Piotroski F-Score of Medical Ikkou Group Co was 9. The lowest was 4. And the median was 6.

Medical Ikkou Group Co  (TSE:3353) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Medical Ikkou Group Co Piotroski F-Score Related Terms


Medical Ikkou Group Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Medical Ikkou Group Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Ikkou Group Co Piotroski F-Score Chart

Medical Ikkou Group Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 5.00 7.00 6.00 5.00

Medical Ikkou Group Co Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 0.00 6.00 0.00 5.00

TSE:3353 vs HON, MMM: Piotroski F-Score Comparison

For the Conglomerates subindustry, Medical Ikkou Group Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Ikkou Group Co Piotroski F-Score vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Medical Ikkou Group Co's Piotroski F-Score falls into.


TSE:3353
68GF Score
Medical Ikkou Group Co Ltd TSE:3353
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb26) TTM:Last Year (Feb25) TTM:
Net Income was 円1,275 Mil.
Cash Flow from Operations was 円1,208 Mil.
Revenue was 円54,983 Mil.
Gross Profit was 円6,486 Mil.
Average Total Assets from the begining of this year (Feb25)
to the end of this year (Feb26) was (34231.775 + 37576.117) / 2 = 円35903.946 Mil.
Total Assets at the begining of this year (Feb25) was 円34,232 Mil.
Long-Term Debt & Capital Lease Obligation was 円7,553 Mil.
Total Current Assets was 円19,146 Mil.
Total Current Liabilities was 円11,618 Mil.
Net Income was 円1,133 Mil.

Revenue was 円48,393 Mil.
Gross Profit was 円5,744 Mil.
Average Total Assets from the begining of last year (Feb24)
to the end of last year (Feb25) was (31659.49 + 34231.775) / 2 = 円32945.6325 Mil.
Total Assets at the begining of last year (Feb24) was 円31,659 Mil.
Long-Term Debt & Capital Lease Obligation was 円6,228 Mil.
Total Current Assets was 円17,965 Mil.
Total Current Liabilities was 円11,669 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medical Ikkou Group Co's current Net Income (TTM) was 1,275. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medical Ikkou Group Co's current Cash Flow from Operations (TTM) was 1,208. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Feb25)
=1275.072/34231.775
=0.0372482

ROA (Last Year)=Net Income/Total Assets (Feb24)
=1133.165/31659.49
=0.03579227

Medical Ikkou Group Co's return on assets of this year was 0.0372482. Medical Ikkou Group Co's return on assets of last year was 0.03579227. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Medical Ikkou Group Co's current Net Income (TTM) was 1,275. Medical Ikkou Group Co's current Cash Flow from Operations (TTM) was 1,208. ==> 1,208 <= 1,275 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Feb26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb25 to Feb26
=7553.067/35903.946
=0.21036872

Gearing (Last Year: Feb25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Feb24 to Feb25
=6227.995/32945.6325
=0.18903856

Medical Ikkou Group Co's gearing of this year was 0.21036872. Medical Ikkou Group Co's gearing of last year was 0.18903856. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Feb26)=Total Current Assets/Total Current Liabilities
=19146.409/11617.672
=1.64804179

Current Ratio (Last Year: Feb25)=Total Current Assets/Total Current Liabilities
=17965.034/11668.666
=1.53959621

Medical Ikkou Group Co's current ratio of this year was 1.64804179. Medical Ikkou Group Co's current ratio of last year was 1.53959621. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Medical Ikkou Group Co's number of shares in issue this year was 3.764. Medical Ikkou Group Co's number of shares in issue last year was 3.76. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=6485.607/54982.518
=0.11795762

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5744.358/48393.487
=0.11870106

Medical Ikkou Group Co's gross margin of this year was 0.11795762. Medical Ikkou Group Co's gross margin of last year was 0.11870106. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Feb25)
=54982.518/34231.775
=1.60618367

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Feb24)
=48393.487/31659.49
=1.5285618

Medical Ikkou Group Co's asset turnover of this year was 1.60618367. Medical Ikkou Group Co's asset turnover of last year was 1.5285618. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+0+1+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medical Ikkou Group Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Medical Ikkou Group Co (TSE:3353) has a Piotroski F-Score of 5 as of Jul. 15, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medical Ikkou Group Co and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Medical Ikkou Group Co's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Medical Ikkou Group Co ranks #271 out of 559 companies in the Conglomerates industry, placing it in the top 48.5%.
Is Medical Ikkou Group Co's Piotroski F-Score too high?
Medical Ikkou Group Co's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Conglomerates industry median Piotroski F-Score is 5.00. Medical Ikkou Group Co's value of 5 is 0% at this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #271 out of 559 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Medical Ikkou Group Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's Piotroski F-Score compare to HON and MMM?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #271 out of 559 companies for Piotroski F-Score. This puts Medical Ikkou Group Co in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Medical Ikkou Group Co's value of 5 is 0% at this benchmark. Historically, Medical Ikkou Group Co's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Medical Ikkou Group Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Conglomerates company?
The median Piotroski F-Score among Conglomerates companies is 5.00, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,534.01, compared to a current price of 円2,841.00 — trading 19.6% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Conglomerates industry median of 5.00. Medical Ikkou Group Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current Piotroski F-Score is 5 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued. The current stock price of 円2,841.00 is trading 19.6% below its estimated GF Value™ of 円3,534.01. GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.

Key valuation signals for TSE:3353:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: 円3,534.01 vs. price of 円2,841.00 (19.6% below fair value)
  • GF Score™: 68/100 with 1 warning sign
  • Industry Position: 0% at the Conglomerates median (#271 of 559)

No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Ikkou Group Co Business Description

Address 501 62 Fujikata, Mie Prefecture, Tsu, JPN, 514-0815
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
68GF Score

Get the complete analysis for TSE:3353

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,841.00
Price
円3,534.01
GF Value